Current Research in Therapeutic Targets

Alzheimer's disease (AD) as of now exhibits one of the greatest medicinal services issues in the created nations. There is no successful treatment equipped for backing off infection movement. As of late the fundamental concentrate of research on novel pharmacotherapies depended on the amyloidogenic speculation of AD, which places that the beta amyloid (Aβ) peptide is primarily in charge of subjective hindrance and neuronal demise. The objective of such medicines is (a) to diminish Aβ creation through the restraint of β and γ secretase chemicals and (b) to advance disintegration of existing cerebral Aβ plaques. Be that as it may, this approach has turned out to be just unobtrusively viable. Late investigations propose an option methodology fixated on the restraint of the downstream Aβ flagging, especially at the neural connection. Aβ oligomers may cause deviant N-methyl-D-aspartate receptor (NMDAR) initiation postsynaptically by shaping buildings with the phone surface prion protein (PrPC). PrPC is enhanced at the neuronal postsynaptic thickness, where it collaborates with Fyn tyrosine kinase. Fyn enactment happens when Aβ is bound to PrPC-Fyn complex. Fyn causes tyrosine phosphorylation of the NR2B subunit of metabotropic glutamate receptor 5 (mGluR5). Fyn kinase blockers masitinib and saracatinib have ended up being effective in treating AD side effects in trial mouse models of the illness.

 

  • Amyloid Plaques
  • Loss of Neuronal Connections and Cell Death
  • Vascular Contributions to Alzheimer’s Disease

Related Conference of Current Research in Therapeutic Targets

September 18-19, 2026

21st Annual Congress on Neuroscience

Dubai, UAE
November 16-17, 2026

35th Euro Congress on Neurologists and Psychiatrists

Tokyo, Japan
November 16-17, 2026

8th World Brain Congress

Tokyo, Japan
November 23-24, 2026

16th Global Alzheimers Summit

Paris, France
November 24-25, 2026

38th World Conference on Neurology

Rome, Italy
December 16-17, 2026

12th International Conference on Brain Injury & Neuro Surgeons

Amsterdam, Netherlands
December 21-22, 2026

6th International Conference on Child Neurology

Paris, France
December 28-29, 2026

18th Global Neurologists Meeting on Neurology and Neurosurgery

Amsterdam, Netherlands
December 28-29, 2026

39th European Neurology Congress

Amsterdam, Netherlands
January 25-26, 2027

22nd Annual Conference on Dementia and Alzheimers Disease

Singapore City, Singapore
February 11-12, 2027

9th World Depression Congress

Tokyo, Japan
March 18-19, 2027

10th World Congress on Epilepsy and Brain Disorders

Paris, France
March 22-23, 2027

8th International Conference on Neurologists

Singapore City, Singapore
March 22-23, 2027

9th World Conference on Neuroscience

Rome, Italy
March 24-25, 2027

38th Conference on Clinical Neuroscience and Neurogenetics

Geneva, Switzerland
April 15-15, 2027

8th Global Summit on Brain Disorders and Therapeutics

Amsterdam, Netherlands
June 14-15, 2027

6th International Conference on Alzheimer and Dementia

Barcelona, Spain
June 24-25, 2027

11th Annual Neurologists and Neurosurgeons Meet

Dublin, Ireland
June 24-25, 2027

19th International Congress on Neurology Surgery

Dublin, Ireland

Current Research in Therapeutic Targets Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in